Compass Therapeutics(CMPX) - 2025 Q3 - Quarterly Results

EXHIBIT 99.1 Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical- stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today reported third quarter 2025 financial results and provided a business update. "We have made strong progress across our clinical pipeline this quarter and based on a continuing trend of lower mortali ...